Trial Profile
A study of ivabradine on LV function and remodeling in patients with STEMI immediately after Percutaneous Coronary Intervention
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Sep 2016
Price :
$35
*
At a glance
- Drugs Ivabradine (Primary)
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- 01 Sep 2016 New trial record